Clinical Trial Update: A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 2/3 study of BJT-778 versus delayed treatment for chronic hepatitis D infection, with the trial currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D

Drugs mentioned

• BJT-778

Snippet

Sponsor: Mirum Pharmaceuticals, Inc. | Conditions: Chronic Hepatitis D Infection | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING